tiprankstipranks
Avalo Therapeutics (AVTX)
NASDAQ:AVTX
Holding AVTX?
Track your performance easily

Avalo Therapeutics (AVTX) Stock Investors

899 Followers
Based on 778,277 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold AVTX
On average, investors allocate 0.00% of their portfolios to AVTX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 778,277 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding AVTX

1.6%
Last 7
Days
3.5%
Last 30
Days
Percentages indicate the change in the number of portfolios holding AVTX, out of 778,277 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

AVTX Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,831 investors who made their portfolios public
The table shows changes in AVTX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

AVTX Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Plug Power
5.22%
-0.54%
-1.69%
2.40B
Industrials
Viking Therapeutics
4.16%
-0.54%
-0.20%
4.78B
Healthcare
DraftKings
4.96%
-0.12%
-0.65%
32.98B
Consumer Cyclical
Block
4.16%
+1.72%
+4.42%
57.12B
Technology
Nio
9.35%
-0.35%
-1.60%
9.37B
Consumer Cyclical
JD
4.89%
-0.13%
-0.92%
54.87B
Consumer Cyclical
Marathon Digital Holdings
5.48%
+0.29%
+2.81%
6.67B
Financial
Riot Platforms
5.16%
+0.09%
+3.85%
4.24B
Financial
Lucid Group
5.71%
-1.06%
+1.38%
9.91B
Consumer Cyclical
Bristol-Myers Squibb
3.41%
-0.41%
+2.34%
114.73B
Healthcare
Based on the activity of 778,277 active portfolios
Open your Smart Portfolio

AVTX Investor Analysis

AVTX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
14.3%
of AVTX holders
are under 35
Average Segment Performance
Average P/E Ratio31.21
Beta10.88
Dividend Yield3.85%
AVTX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
48.1%
of AVTX holders
are between 35–55
Average Segment Performance
Average P/E Ratio28.03
Beta19.53
Dividend Yield3.58%
AVTX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
37.7%
of AVTX holders
are over 55
Average Segment Performance
Average P/E Ratio26.38
Beta10.27
Dividend Yield3.51%
Overview of age group and performance of AVTX stock investors
See who invests in AVTX according to age group and performance.

FAQ

How many retail Investors hold AVTX?
<0.1% of TipRanks' retail investors hold AVTX in their portfolios.
    What is AVTX Investor Sentiment?
    AVTX’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of AVTX in the last 7 days?
      ▼ 1.6% of TipRanks' retail investors changed their holding of AVTX in the last 7 days.
        What percentage of retail investors changed their holding of AVTX in the last 30 days?
        ▼ 3.5% of TipRanks' retail investors changed their holding of AVTX in the last 30 days.
          What is the average age of retail investors who hold AVTX?
          The average age of AVTX Holders is between 35–55.
            What other stocks have AVTX investors also bought?
            AVTX Investors also bought PLUG, VKTX, DKNG, SQ, NIO, JD, MARA, RIOT, LCID, BMY.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              ANGOAngioDynamics
              BCRXBioCryst
              BMRNBioMarin Pharmaceutical
              LCTXLineage Therap
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis